Correlation of histopathologic/cytologic follow-up findings with vaginal ASCUS and ASC-H papanicolaou test and HPV test results

American Journal of Clinical Pathology

Volumn 137, Issue 3, 2012, Pages 437-443

  Bansal, Mona ^a   Li, Zaibo ^a   Zhao, Chengquan ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

ASC H; ASC US; Atypical squamous cells of undetermined significance; Atypical squamous cells, cannot exclude HSIL; Human papillomavirus; Vaginal cytology; Vaginal intraepithelial neoplasia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; CYTOPATHOLOGY; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HPV TEST; HUMAN; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SEROPREVALENCE; SQUAMOUS CELL; VAGINA CYTOLOGY; VAGINAL ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; VAGINAL INTRAEPITHELIAL NEOPLASIA; ALPHAPAPILLOMAVIRUS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; EMERGENCY HEALTH SERVICE; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

VIRUS DNA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COST-BENEFIT ANALYSIS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRIAGE; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84859224604     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP9TO1OMXLDDPI     Document Type: Article

References (40)

1. Saslow D, Runowicz CD, Solomon D, et al.American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. J Low Genit Tract Dis. 2003;7:67-86. (Pubitemid 36469352)
2. ACOG Practice Bulletin No. 109: cervical cytology screening. Obstet Gynecol. 2009;114:1409-1420.
3. Schockaert S, Poppe W, Arbyn M, et al.Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study. Am J Obstet Gynecol. 2008;199:113.e1-113.e5. doi:.
4. Ferris DG, Messing MJ, Crosby JH. Vaginal intraepithelial neoplasia III detected after hysterectomy for benign conditions. J Fam Pract. 1995;40:81-85.
5. Pearce KF, Haefner HK, Sarwar SF, et al.Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease. N Engl J Med. 1996;335:1559-1562. (Pubitemid 26384750)
6. Noller KL. Screening for vaginal cancer. N Engl J Med. 1996;335:1599-1600. (Pubitemid 26384758)
7. Farghaly H, Bourgeois D, Houser PM, et al.Routine vaginal Pap test is not useful in women status-post hysterectomy for benign disease. Diagn Cytopathol. 2006;34:640-643. (Pubitemid 44298568)
8. Fetters MD, Lieberman RW, Abrahamse PH, et al.Cost-effectiveness of Pap smear screening for vaginal cancer after total hysterectomy for benign disease. J Low Genit Tract Dis. 2003;7:194-202. (Pubitemid 36958102)
9. Wiener JJ, Sweetnam PM, Jones JM. Long term follow up of women after hysterectomy with a history of pre-invasive cancer of the cervix. Br J Obstet Gynaecol. 1992;99:907-910.
10. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53:27-43. (Pubitemid 36163620)
11. Kendall BS, Zahn CM. The use of reflex high-risk human papillomavirus testing for atypical squamous cells of undetermined significance interpretations on vaginal specimens. Cancer. 2009;117:27-31.
12. Bansal M, Zhao C. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology. J Low Genit Tract Dis. 2011;15:105-109.
13. Solomon D, Davey D, Kurman R, et al.The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119. (Pubitemid 34437346)
14. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med. 2003;127:946-949. (Pubitemid 36994853)
15. Kinney WK, Manos MM, Hurley LB, et al.Where's the high-grade cervical neoplasia? the importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol. 1998;91:973-976. (Pubitemid 28246934)
16. Wright TC Jr., Massad LS, Dunton CJ, et al.2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007;197:340-345. (Pubitemid 47464166)
17. Arbyn M, Buntinx F, Van Ranst M, et al.Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst. 2004;96:280-293. (Pubitemid 38256273)
18. Davey E, d'Assuncao J, Irwig L, et al.Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study. BMJ. 2007;335:31.doi:.
19. Castle PE, Lorincz AT, Scott DR, et al.Comparison between prototype Hybrid Capture 3 and Hybrid Capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer. J Clin Microbiol. 2003;41:4022-4030. (Pubitemid 37099659)
20. Armah H, Austin RM, Dabbs D, et al.Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice. Arch Pathol Lab Med. 2009;133:1426-1430.
21. Bandyopadhyay S, Austin RM, Dabbs D, et al.Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med. 2008;132:1874-1881.
22. Saminathan T, Lahoti C, Kannan V, et al.Postmenopausal squamous-cell atypias: a diagnostic challenge. Diagn Cytopathol. 1994;11:226-230. (Pubitemid 24341234)
23. Abati A, Jaffurs W, Wilder AM. Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer. 1998;84:218-225. (Pubitemid 28385560)
24. Bulten J, de Wilde PC, Boonstra H, et al.Proliferation in "atypical" atrophic Pap smears. Gynecol Oncol. 2000;79:225-229.
25. Jovanovic AS, McLachlin CM, Shen L, et al.Postmenopausal squamous atypia: a spectrum including "pseudo-koilocytosis." Mod Pathol. 1995;8:408-412.
26. Flynn K, Rimm DL. Diagnosis of "ASCUS" in women over age 50 is less likely to be associated with dysplasia. Diagn Cytopathol. 2001;24:132-136. (Pubitemid 32108523)
27. Ferenczy A, Gelfand MM, Franco E, et al.Human papillomavirus infection in postmenopausal women with and without hormone therapy. Obstet Gynecol. 1997;90:7-11. (Pubitemid 27272946)
28. Burk RD, Kelly P, Feldman J, et al.Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis. 1996;23:333-341. (Pubitemid 26250669)
29. Kaminski PF, Sorosky JI, Wheelock JB, et al.The significance of atypical cervical cytology in an older population. Obstet Gynecol. 1989;73:13-15. (Pubitemid 19020996)
30. Rader AE, Rose PG, Rodriguez M, et al.Atypical squamous cells of undetermined significance in women over 55: comparison with the general population and implications for management. Acta Cytol. 1999;43:357-362. (Pubitemid 29239297)
31. Sawaya GF, Grady D, Kerlikowske K, et al.The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/Progestin Replacement Study (HERS). Ann Intern Med. 2000;133:942-950. (Pubitemid 32003510)
32. Keating JT, Wang HH. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women. Cancer. 2001;93:100-105. (Pubitemid 32322163)
33. Zhao C, Zhao S, Heider A, et al.Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell Papanicolaou test abnormalities. Arch Pathol Lab Med. 2010;134:1130-1135.
34. Rosario D, Zahn CM, Bush AC, et al.The significance of high-risk human papillomavirus detection in women aged > or = 50 years with atypical squamous cells of undetermined significance cytologic preparations. Cancer. 2007;111:487-490. (Pubitemid 350304900)
35. Cuzick J, Beverley E, Ho L, et al.HPV testing in primary screening of older women. Br J Cancer. 1999;81:554-558. (Pubitemid 29458814)
36. Herrero R, Hildesheim A, Bratti C, et al.Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92:464-474. (Pubitemid 30182883)
37. Eltoum IA, Chhieng DC, Roberson J, et al.Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women. Cancer. 2005;105:194-198. (Pubitemid 41176998)
38. Saad RS, Dabbs DJ, Kordunsky L, et al.Clinical significance of cytologic diagnosis of atypical squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women. Am J Clin Pathol. 2006;126:381-388. (Pubitemid 44338790)
39. Srodon M, Stoler MH, Baber GB, et al.The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol. 2006;30:1513-1518. (Pubitemid 44808787)
40. Srodon M, Parry Dilworth H, Ronnett BM. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results. Cancer. 2006;108:32-38. (Pubitemid 43291241)